the studies demonstrated the immunological and epidemiological effectiveness of a single injection of adsorbed diphtheria-tetanus toxoid with reduced antigen content for adults : intense antidiphtheria immunity in 92.3 % of the vaccinees 1-3 months and in 94.5 % of the vaccinees 1 year after the injection .
C0003320
antigen
C0020964
immunity